High Purity Retatrutide 5mg+cagrilintide 5mg RC10 10mg Peptide 99% Pharmaceutical Grade Weight Loss Peptide
76 Inquiries
70-18-8
Pharmaceutical Grade
99%
shanghai
JL
10ml
2027-08-18
Peptide
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceL-Glutathione reduced (GSH; γ-L-Glutamyl-L-cysteinyl-glycine) is an endogenous antioxidant and is capable of scavenging oxygen-derived free radicals.
Solid
Glutathione is a tripeptide compound consisting of glutamic acid attached via its side chain to the N-terminus of cysteinylglycine. It has a role as a skin lightening agent, a human metabolite, an Escherichia coli metabolite, a mouse metabolite, an antioxidant and a cofactor. It is a tripeptide, a thiol and a L-cysteine derivative. It is a conjugate acid of a glutathionate(1-).|A tripeptide with many roles in cells. It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes, is involved in protein disulfide bond rearrangement and reduces peroxides.|Glutathione is a tripeptide comprised of three amino acids (cysteine, glutamic acid, and glycine) present in most mammalian tissue. Glutathione acts as an antioxidant, a free radical scavenger and a detoxifying agent. Glutathione is also important as a cofactor for the enzyme glutathione peroxidase, in the uptake of amino acids, and in the synthesis of leukotrienes. As a substrate for glutathione S-transferase, this agent reacts with a number of harmful chemical species, such as halides, epoxides and free radicals, to form harmless inactive products. In erythrocytes, these reactions prevent oxidative damage through the reduction of methemoglobin and peroxides. Glutathione is also involved in the formation and maintenance of disulfide bonds in proteins and in the transport of amino acids across cell membranes.Basic Info-
Product Name:
Glutathione
Other Name:Glycine,L-γ-glutamyl-L-cysteinyl-;Glutathione;Glycine,N-(N-L-γ-glutamyl-L-cysteinyl)-;L-γ-Glutamyl-L-cysteinylglycine;γ-L-Glutamyl-L-cysteinylglycine;Glutathione-SH;GSH;L-Glutathione;Reduced glutathione;Triptide;Glutide;Tathion;Tathione;Copren;Deltathione;Glutathion;Glutinal;Isethion;Neuthion;Agifutol S;γ-Glutamylcysteinylglycine;N-(N-L-γ-Glutamyl-L-cysteinyl)glycine;Bakezyme RX;ReadiSorb;Atomolan;High Thione Extract YH 15;N5-((R)-1-((Carboxymethyl)amino)-3-mercapto-1-oxopropan-2-yl)-L-glutamine;TAD 600;1109226-07-4;1655518-50-5
CAS No.:70-18-8
Molecular Formula:C10H17N3O6S
InChIKeys:InChIKey=RWSXRVCMGQZWBV-WDSKDSINSA-N
Molecular Weight:307.32300
Exact Mass:307.32
EC Number:200-725-4
UNII:GAN16C9B8O
NSC Number:758199
DSSTox ID:DTXSID6023101
NCI Thesaurus Code:C523
ATC Code:V - Various
HScode:2930909090
Categories:
Characteristics-
PSA:
197.62000
XLogP3:-4.5
Appearance:Solid
Density:1.441 g/cm3
Melting Point:195 °C
Boiling Point:410.1ºC
Flash Point:410.1±32.9 °C
Refractive Index:1.571
Water Solubility:H2O: 292.5 mg/mL
Storage Conditions:2-8ºC
Collision Cross Section:167.4 Ų [M+H]+ [CCS Type: DT, Method: single field calibrated with Agilent tune mix (Agilent)]|168.23 Ų [M+Na]+ [CCS Type: DT, Method: stepped-field]|164.24 Ų [M-H]- [CCS Type: DT, Method: stepped-field]|165 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine]|167.8 Ų [M+H]+ [CCS Type: DT, Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]|167 Ų [M+Na]+ [CCS Type: DT, Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]|162.1 Ų [M-H]- [CCS Type: DT, Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]|164.8 Ų [M+Na-2H]- [CCS Type: DT, Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]|165.7 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]|164.8 Ų [M-2H+Na]-
Research-
Class:
Amylin receptor (AMYR) / calcitonin receptor (CTR) agonist (long-acting amylin analog)
Status:Investigational — Phase 3 (REDEFINE program, CagriSema combination)
Mechanism:A novel long-acting, acylated amylin (islet amyloid polypeptide, IAPP) analog consisting of 38 amino acids. Cagrilintide activates the amylin receptor (AMYR) and calcitonin receptor (CTR), reducing food intake, delaying gastric emptying, and promoting satiety. Being developed as monotherapy and in fixed-dose combination with semaglutide (CagriSema) for obesity. Administered once weekly.
Activity note:Cagrilintide is a non-selective AMYR/CTR agonist. Specific EC50 values not publicly available; functional potency is comparable to native amylin at AMYR.
Source:MCE: Cagrilintide (CAS 1415456-99-3); Novo Nordisk REDEFINE program.
Clinical Development:
References-
PubChem:Literature:
MCE: Cagrilintide (CAS 1415456-99-3); ClinicalTrials.gov: REDEFINE-1 (NCT05249895); Novo Nordisk: EASD 2025 Cagrilintide data presentation
Disclaimer:Cagrilintide is NOT FDA-approved or EMA-approved. It is in Phase 3 clinical trials (REDEFINE program). This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Hazard IdentificationClassification of the substance or mixture
Not classified.
GHS label elements, including precautionary statements
Pictogram(s) No symbol. Signal word No signal word
Hazard statement(s) none
Precautionary statement(s) Prevention none
Response none
Storage none
Disposal none
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Peptide
-
Location:
zhejiangshengjinhuashiyiwushijiangdongjiedaodongnanlu656hao
-
Average lead Time:
15
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
5-10
-
Year of Establishment:
2026
-
-
Inquiry History76 Inquiries
Country Product Purchase Quantity Date Posted 
United States
Glutathione Quality Research Chemical Peptide Cas Number 70-18-8 Lyophilized Powder
50 PCS Apr 14, 2026 
Colombia
Glutathione | Peptides | 99% Purity | CAS 70-18-8 | White Powder | Antioxidant Detox
5 G May 12, 2026 
India
Glutathione
100.00 G Nov 22, 2024 
Germany
glutathione
1 KG Aug 28, 2026
United States
glutathione
20 MG Aug 26, 2026 
Philippines
Glutathione
50 MG Aug 19, 2026
United States
Glutathione
1 MG Aug 10, 2026
United States
Glutathion
100 MG Aug 3, 2026 
United Kingdom
Glutathione
10 MT Jul 30, 2026
United States
Glutathione
100 MG Jul 27, 2026
United Kingdom
Glutathione 1200mg
50 Jul 23, 2026 
Canada
Glutathione
10 G Jul 16, 2026
United States
Glutathione
500 PCS Jun 6, 2026 
South Africa
Glutathione
50 MG Jun 1, 2026
United States
Glutathione
10 MT May 29, 2026
United Kingdom
Glutathione
100 G May 16, 2026
United States
Glutathione
1500 MG May 8, 2026
United States
Glutathione
1000 MG Apr 3, 2026
United States
Glutathione 1500
100 MT Mar 26, 2026
United States
Glutathione
1500 BOU Mar 16, 2026 Post an enquiry for this product
